Lidocaine for Treating Scleroderma
Author Information
Author(s): Riera Rachel, Andrade Luís EC, Souza Alexandre WS, Kayser Cristiane, Yanagita Edison T, Trevisani Virgínia FM
Primary Institution: Universidade Federal de São Paulo - Escola Paulista de Medicina
Hypothesis
Is lidocaine effective and safe for treating systemic sclerosis?
Conclusion
Lidocaine did not show efficacy in treating scleroderma despite previous studies suggesting otherwise.
Supporting Evidence
- 66.7% of the placebo group showed improvement in skin score compared to 50% in the lidocaine group.
- No significant adverse effects were reported in either group.
- Both groups reported similar improvements in subjective self-assessment.
Takeaway
This study tested if lidocaine could help people with a disease called scleroderma, but it didn't work as hoped.
Methodology
A double-blind randomized clinical trial with 24 patients receiving either lidocaine or placebo over three cycles.
Potential Biases
Low risk of bias due to randomization and blinding.
Limitations
The study included patients with more than two years since the first symptom and used a fixed dosage of lidocaine.
Participant Demographics
12 males and 12 females, aged 40-41 years on average.
Statistical Information
P-Value
0.408
Statistical Significance
p = 0.408
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website